KCs respond to antigenic, damage-associated, or microbe-derived signals by secreting IL-10 and other immunosuppressive cytokines, and they express the immune checkpoint ligand PD-L1, which significantly hampers the immune system’s capacity to identify and eliminate tumor cells. The gene discussed is CD274; the disease is neoplasm.